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Abstract 
At St Thomas' Hospital, we have developed a computer program on a Titan graphics 
supercomputer to plan the stereotactic implantation of iodine-125 seeds for the palliative 
treatment of recurrent malignant gliomas. Use of the Gill-Thomas-Cosman relocatable frame 
allows planning and surgery to be carried out at different hospitals on different days. 
Stereotactic computed tomography (CT) and positron emission tomography (PET) scans are 
performed and the images transferred to the planning computer. The head, tumour and frame 
fiducials are outlined on the relevant images, and a three-dimensional model generated. 
Structures which could interfere with the surgery or radiotherapy, such as major vessels, 
shunt tubing etc., can also be outlined and included in the display. Catheter target and entry 
points are set using a three-dimensional cursor controlled by a set of dials attached to the 
computer. The program calculates and displays the radiation dose distribution within the 
target volume for various catheter and seed arrangements. The CT co-ordinates of the fiducial 
rods are used to convert catheter co-ordinates from CT space to frame space and to calculate 
the catheter insertion angles and depths. The surgically implanted catheters are after-loaded 
the next day and the seeds left in place for between 4 and 6 days, giving a nominal dose of 50 
Gy to the edge of the target volume. 25 patients have been treated so far. 
 
 
Stereotactic implantation of radioactive iodine-125 seeds has been used in treating primary 
and recurrent malignant gliomas since the 1980's [1-3]. Iodine-125 is our radionuclide of 
choice as it has a lower energy of X-ray and gamma emission (27-35 keV) than other 
radionuclides used for brachytherapy, for instance, iridium-192 (296-468 keV). The half 
value layer (HVL) for iodine-125 is only 0.025 mm lead, compared with 2.5 mm lead for 
iridium-192 [4]. Consequently, iodine-125 has a steeper dose fall-off curve than iridium-192. 
Rosenow et al [5] have compared absorbed dose distributions around various configurations 
of iodine-125 and iridium-192 sources and concluded that the difference in dose distributions 
between iodine-125 and iridium-192 in the vicinity of the target volume is unlikely to be 
significant. However, the increased dose to the whole brain with iridium-192 may be a matter 
of concern. The main advantage of using iodine-125 over other commonly used radionuclides 
is the easier implementation of radiation protection. 
 
As a large number of calculations are required to produce a radiation dose distribution in the 
vicinity of a target volume, a fast computer is needed to generate a plan in a reasonable time 
[6,7]. In recent years there has been a dramatic decrease in the cost of computers with 
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sufficient power to handle real time three-dimensional (3D) graphics, i.e. computers able to 
manipulate and display 3D images in just a few seconds. We have developed a 125I 
stereotactic brachytherapy planning system that makes use of a state-of-the-art graphics 
supercomputer combining high speed computation with high quality 3D graphics. So far, the 
system has been used in the palliative treatment of 25 patients with recurrent malignant 
gliomas [8]. 
 
Methods and materials 
The computer program was developed on a Titan graphics super-computer (Kubota Pacific 
Inc., Santa Clara, CA, USA) with four central processor units, each nominally rated at 16 
million floating point operations per second (MFLOPS) and 16 million instructions per 
second (MIPS). The computer has 64 Mbytes of on-board memory and 2.3 Gbytes of disc 
space. A half inch magnetic tape drive is attached to transfer computed tomography (CT) 
images onto the hard disc. 
 
The software was developed using the UNIX operating system, C programming language, X-
windows graphical user interface and a 3D graphics library; dynamic object rendering 
environment (Dore) enabling the specification of the size, shape, position, colour, lighting, 
etc., of objects in a 3D display.  
 
For the majority of patients planned on the system, the Gill-Thomas-Cosman (GTC) 
relocatable frame (Radionics Inc., Burlington, MA, USA) is used [8-10]. An impression of 
the patient's upper teeth is taken using a dental mould fitted into a dental tray. Once hardened, 
this tooth impression supplies a unique fit to the patient's upper dentition. The dental tray 
attaches to the base of the GTC frame and is the key to the frame's relocatability. Early 
estimates [9] of the mean accuracy of repeat fixation of 0.5 mm or less have been re-
confirmed clinically by us [11] and others (J Loeffler, personal communication, 1993). The 
side straps are tightened to stabilize the frame and the rubberized occipital mould provides 
further stabilization. The relocatability of the frame enables planning and surgery to be 
carried out on different days and at different centres. In contrast, the standard Brown-
Roberts-Wells (BRW) frame is fixed to the head using four skull pins requiring surgery to be 
carried out within a few hours of fixation (or at least on the same day).  
 
The GTC frame is fitted to the patient in the scanner room, and a BRW CT localizer ring 
(Figure 1) locked into place on the base ring. The BRW CT localizer comprises nine fiducial 
rods which enable the transformation of CT image points to BRW co-ordinates. A series of 
contrast enhanced CT images (Figure 2) is taken using a Siemens Somaton DRH scanner 
(Siemens AG, Erlangen, Germany). Typically, 15-30 images (512 x 512 matrix, 0.625 mm 
square pixels, and 4 mm slice thickness) are required to encompass the target volume and 
allow some margin above and below. 
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Figure 1. Relocatable GTC frame with BRW CT localizer. 
 
 
 
 
Figure 2. CT image showing the head and target volume (malignant glioma) and fiducial rods. 
 
Extra slices are acquired superior to the target volume in order to have more flexibility in 
planning catheter trajectories. The images are transferred to the planning computer on half 
4 
 
inch magnetic tape. Prior to CT scanning, a plastic face mask is inserted underneath the GTC 
straps. Four polythene markers, each containing a small (2 mm diameter) spherical chamber 
for receiving 18 fluorodeoxyglucose (FDG), are taped onto the mask. These appear on both 
the CT and positron emission tomography (PET) images enabling co-registration of the target 
volume. After the CT scan, FDG is injected into the markers on the mask and the patient is 
scanned on a Siemens ECAT 951R scanner. Each image (Figure 3) has a 128 matrix, 2 mm 
pixels, and slice thickness of 3.2 mm. The PET and CT images are co-registered (Figure 4) 
using a program developed on a Sun Sparc Station 2, by the Division of Radiological 
Sciences, United Medical and Dental Schools, Guys and St Thomas' Hospital, London [12]. 
 
 
Figure 3. PET image showing target volume. 
 
 
Figure 4. Co-registered target volume surfaces based on the CT and PET data (white and pink, respectively). 
The four PET-CT fiducial markers are displayed in green. 
 
 
Computer planning 
The head, target volume, fiducials and any other relevant structures are outlined on the 
appropriate slices. The head is outlined automatically by an edge tracing algorithm initiated 
by clicking the mouse over the skin-air interface. The target volume is outlined manually and 
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is taken as the region of contrast with no added margin. Other structures which might 
influence the plan, for example, eyes, brain stem, shunt tubing and blood vessels are also 
outlined. The target volume is also outlined on the PET images. Bright areas on the PET 
images correspond to the most active areas of the tumour. Catheter trajectories are adjusted to 
ensure that the most active regions of the tumour receive the prescribed dose; if necessary, at 
the expense of other regions within the CT enhancing rim.  
 
The outlines are displayed as a stack inside a reference box (Figure 5). A set of dials attached 
to the computer enables manipulation of the view and controls the position of a 3D cursor 
used for marking catheter entry and target points. 
 
The primary purpose of the planning program is to choose catheter trajectories and seed 
arrangements which provide an optimal dose distribution to the target volume. Ideally, the 
catheters and seeds would be arranged in parallel planes to ensure all of the target volume 
receives a uniform treatment. However, this is difficult to achieve in the brain as there are a 
number of neurosurgical and radiotherapy considerations which need to be taken into 
account. Ideally, catheters should be routed to avoid eloquent areas of the brain, blood 
vessels, shunts, burr holes, bone flaps etc. In some cases parts of the GTC frame get in the 
way, for example the straps or occipital block. Surface renderings of skin and bone, generated 
from the CT data are useful for showing the position of previous burr holes and craniotomy 
flaps (Figure 6). 
 
The dose received by critical structures by previous external beam radiotherapy must also be 
taken into account. For instance, if the target volume lies in one of the visual cortices, and 
both cortices have previously been irradiated, the dose to the normal cortex must be kept as 
low as possible to avoid further impairment of vision. 
 
 
 
Figure 5. Head and target volume displayed inside a reference box. The target volume outlines and position 3D 
cursor are projected onto orthogonal sides of the box, as an aid to setting catheter trajectories. 
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Figure 6. Surface display of the skin, nine fiducial rods, tumour (blue) and isodose surface (red). (The green 
ball is the 3D cursor). 
 
As radiation causes swelling of brain tissue, particular care must be taken in the region of the 
brain stem. We endeavour to use as few catheters as possible to reduce the risk of 
haemorrhage and damage to normal brain, and therefore accept a certain degree of dose 
inhomogeneity. In our series of 63 implanted catheters (first 20 patients) there was one case 
(1.6%) of symptomatic haemorrhage (hemiparesis) and five cases (7.9%) of asymptomatic 
haemorrhage. These numbers are slightly worse than the 4.7% complication rate for biopsies 
reported by Thomas and Nouby [13].  
 
As the 125I seeds are distributed along the length of a catheter, the catheter trajectory is very 
important. Even if a catheter contains only one seed, the trajectory must still be taken into 
account because of the anisotropic dose distribution around the seed. Thomson et al [14] has 
noted the importance of planning entry positions prior to surgery, as any changes made at the 
time of surgery will invalidate the chosen plan. In our system, the preferred region of entry 
from a surgical point of view is sometimes marked on the CT images and shown in the 3D 
display. 
 
Positioning of the entry and target points is aided by the projection of the target volume 
outlines and 3D cursor onto three orthogonal sides of the box (Figure 5). The three projection 
spheres move as the cursor is moved, making it easy to see when the cursor is inside the 
target volume. 
 
When a provisional arrangement of catheters has been obtained, the next stage of planning is 
to calculate the dose distribution for different seed arrangements. Seeds of between 0.37 and 
1.29 GBq (10 and 35 mCi) in activity are selected from a database, assigned to a catheter, and 
positioned 5, 10, 15 or 20 mm apart. (The seeds could of course be separated at intermediate 
distances, but this degree of refinement is probably unnecessary.)  
 
The number of catheters implanted ranged from one to four (with a mean of two), containing 
2-15 seeds (mean of six) with a total activity of 1.48 to 8.9 GBq (40 to 230 mCi) with a mean 
of 4.5 ± 2.0 GBq (121 ± 53 mCi). The entry and target points had a mean separation of 2.35 ± 
1.09 cm and 2.17 ± 0.7 cm, respectively. The target volumes ranged from 4 to 66 cm3 with a 
mean of 28 ± 17cm3. 
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A useful feature of the program is the plotting of 50 cGy h-1 isodose spheres isocentric with 
the seeds (Figure 7). The catheter trajectories are adjusted to fill the target volume as evenly 
as possible. Although the spheres represent an isotropic dose distribution, and the influence 
of each seed on the others around it is not taken into account, an approximate plan can be 
produced in a matter of minutes. 
 
The dose distribution is calculated using the empirical equation developed by Schell et al [15] 
which models the anisotropic dose distribution around IMC 6702 (Amersham International 
Plc, Amersham, UK) iodine seeds in water. 
 
 
 
 
Figure 7. Isodose spheres concentric with seeds. 
 
To calculate the 3D dose distribution, a grid is constructed around the target volume. The grid 
is made 10% larger than the maximum dimensions of the target volume in the x, y and z 
directions. The grid spacing is set to either 0.625 or 1.25 mm which is well within the 
suggested spacing of 2-5 mm [16].  
 
Schell et al give data for the relative dose rate versus distance for five discreet angles (90°, 
150°, 160°, 170° and 180°); 90° is perpendicular to the long axis of the seed. When the 
program is initialized, a distance-dose lookup table is generated for the five angles. To 
calculate the dose rate at a point on the grid, the distance between the centre of each seed and 
grid point is calculated, and the angle between this line and the long axis of the seed. The 
distance is converted into an entry for the distance dose rate look-up table. 
 
For intermediate angles, the dose is found by linear interpolation. The error in interpolating 
between angles was estimated by interpolating between 90° and 160°, 150° and 170°, 160° 
and 180°, and comparing the results with the values at 150°, 160° and 170°, respectively. The 
error is likely to be half of that calculated, as in the dose rate calculation interpolation is 
carried out over half the interval (except for 90-150°). Table I shows the estimated errors for 
interpolating between the given angles at different distances. 
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The absorbed dose is calculated from: 
 dose = 𝑓Γ𝐴
𝑟2
𝐷(𝜃, 𝑟) (1) 
 
 
𝑓 = 0.873 (𝜇𝑒𝑛 𝜌⁄ ) water(𝜇𝑒𝑛 𝜌⁄ ) air = 0.874 for 30 keV photons    (2) 
 
 
D(θ,r) is the Schell function giving dose as a function of angle and distance (r) in cm 
normalized by multiplying by r2. µen is the linear energy absorption coefficient. Γ is the 
specific gamma rate constant = 1.45 R h -1 mCi-1 at 1 cm. A is the activity in mCi. For 1.48 
GBq (40 mCi), the absorbed dose is 50.7 cGy h-1 at 1 cm. The Schell doses were compared 
with those found by Krishnaswamy [17] (Table II). There are bound to be errors associated 
with taking the dose distribution in water; however, these errors are likely to be insignificant 
in comparison with the error in delineating the boundary of the target volume. By default the 
dose distribution is integrated over 100 h, but the integration time may be adjusted as 
necessary (typical values are 100-144 h, i.e. 4-6 days).  
 
 
Table I. Percentage error estimates of angles using the Schell function [15] 
 
Angle 
(degrees) 
Distance (cm) 
1 2 3 4 5 
150 0.2 0.8 1.4 2.1 2.4 
160 1.8 1.9 2.2 2.4 2.2 
170 2.5 2.5 2.2 2.0 1.7 
 
 
 
 
Table II. Comparison between the dose values calculated by the Schell function [15] and those measured by 
Krishnaswamy [17] 
Distance (cm) Krishnaswamy [17] Schell [15] % difference 
1 1.32 1.27 3.8 
2 0.285 0.26 8.8 
3 0.102 0.092 9.8 
4 0.044 0.0399 9.3 
5 0.021 0.0193 8 
 
We aim to deliver 50 ± 10 Gy to as much of the edge of the target volume as possible, 
although a section of the edge is sometimes under dosed if the tumour is close to the brain 
stem or next to a critical structure (e.g. visual cortex) that has already received 40 or 50 Gy 
from external beam radiotherapy.  
 
Initially, an isotropic dose calculation is performed which is much quicker than the 
anisotropic calculation as only distances have to be calculated. A full anisotropic calculation 
is carried out when the isotropic dose distribution appears to be satisfactory. For the plan 
illustrated in this paper, (five seeds and 15 650 grid points), the isotropic calculation took 10 s 
and the anisotropic 35 s. 
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Visually, there is not a big difference between the isotropic and anisotropic dose calculations; 
however, there is a marked difference between the dose-surface and dose-volume histograms 
(Figure 8). For the isotropic calculation, 77.5% of the volume is above 40 Gy, compared with 
73.6% for the anisotropic calculation. Similarly, 36.7% of the surface is above 40 Gy for the 
isotropic calculation, compared with 26.7% for the anisotropic calculation. These results 
show the importance of taking anisotropy into account. 
 
 
(a) 
 
(b) 
Figure 8. (a) Dose-surface histogram, (b) Dose-volume histogram. Shaded bars are for the isotropic dose 
calculation. Each bar represents the percentage of the surface or volume within, or above, the designated dose 
range. 
 
 
The program also calculates the volume of normal tissue receiving more than 50 Gy, the 
volume of tumour and normal tissue receiving more than 100 Gy [16] and the mean and 
minimum dose. The values for the plan illustrated in this paper are shown in Table III. The 
minimum dose value is low, as it is difficult to achieve a good dose distribution on every 
slice, especially at the top and bottom extremities, due to the limitations described above. 
However, bearing in mind that the treatment of gliomas is palliative, a dose less than the 
prescription to a small part of the tumour will be of some benefit to the patient. 
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A 3D isodose surface is generated and displayed with a surface representation of the target 
volume (Figure 9). Regions of overdosing occur where the isodose surface hides the surface 
of the target volume and vice versa. The dose distribution is also calculated on grid planes 
corresponding to the CT slices and displayed over the CT images (Figure 10). Catheter 
trajectory projections can be displayed on the CT slice. Tracks appear blue if above a CT 
slice, and red if below. 
 
Comparison of plans can also be carried out visually by plotting differences between dose 
distributions. This is done by loading two pre-calculated dose distributions into memory and 
comparing corresponding grid points with a pre-selected threshold, for instance, 50 Gy. If a 
particular point in the first plan is above 50 Gy, and the corresponding point in the second 
plan is below 50 Gy, a red dot is plotted. If the reverse is the case then a blue dot is plotted. 
Areas of red indicate where the first plan is better than the second, and vice versa for blue. 
 
Table III. Volume of normal tissue above 50 Gy, volume of tissue (tumour and normal) above 100 Gy, and the 
mean and minimum dose to the target volume 
 
 Vol. normal tissue 
>50 Gy (cm3) 
Vol. normal tissue 
>100 Gy (cm3) 
Mean dose (Gy) Min. dose (Gy) 
Isotropic 0.78 6.71 37.3 3.5 
Anisotropic 0.42 5.93 34.4 3.3 
 
 
 
 
 
Figure 9. An isodose surface (red) displayed with the tumour surface. Areas of red indicate overdosing and vice 
versa for blue. 
 
A transformation matrix, calculated from the CT co-ordinates of the fiducials, is used to 
convert the x, y, z co-ordinates of the catheter target and entry points to BRW anterior-
posterior (AP), lateral (LAT) and vertical (VERT) co-ordinates. If a target or entry point falls 
between CT slices, as often will be the case, the transformation matrix is calculated using 
interpolated fiducial co-ordinates. As a check, the calculations are repeated using the STAX 
program on a Radionics SCSI portable computer. The STAX program is used to calculate the 
BRW arc angles and depths required for surgical implantation of the catheters. 
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Figure 10. Dose distribution on a CT image. Red represents 60 Gy or above, yellow 40-60 Gy and blue 40-20 
Gy. 
 
 
Surgery 
Surgery is usually carried out at The National Hospital for Neurology and Neurosurgery, 
Queen Square, London, 2 days after the planning scans. The base ring of the GTC frame is 
fitted to the patient in the anaesthetic room after the induction of general anaesthesia. To 
ensure that the frame has been applied correctly, the distance of the lower tip of the ear lobes 
above the base ring are measured, and compared with measurements made in the scanner 
room. The BRW arc system is fitted after the GTC frame has been bolted to the operating 
table. 
 
Standard Gutin afterloading catheters are used [18]. At the end of the procedure, the catheter 
target positions are checked by inserting 20 gauge stainless steel wire into the catheters and 
taking orthogonal plane X-rays with a Radionics SGV-AL stereographic localizer box 
attached to the base of the GTC frame [11]. If the actual target positions are out by up to 5 
mm, the plan is adjusted by altering the arrangement of seeds inside the catheters. In some 
cases re-positioning of the catheters is necessary. It should be borne in mind that over the 
course of the treatment there may be some displacement of the catheters relative to the target 
volume due to swelling of the brain or scalp induced by the surgery or radiation. 
 
Afterloading 
The 125I seeds are loaded into the inner catheters at St Thomas' Hospital. Plastic spacers 5 
and 10 mm in length are used to separate seeds. A thin nylon tube is inserted into the catheter 
to keep the seeds in place. The seed activities are checked against the activity calculated from 
the supplied calibration certificate using a Capintec radioisotope calibrator (Capintec Inc., 
Ramsey, NJ, USA). The total activity in each catheter is also measured as a final check. The 
inner catheters are transported to the National Hospital for Neurology and Neurosurgery and 
administered the day after surgery if there are no contraindications.  
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Exposure measurements are made at 1 m, on the side of the tumour [19]. The patient is 
confined to a room on their own for the duration of the treatment. Visitors are instructed to sit 
more than 1 m away from the patient, preferably on the opposite side to the tumour. Patients 
usually go home the day after the seeds are removed. Follow-up CT and PET scans are 
carried out 6 weeks later. 
 
Discussion 
The St Thomas' Hospital brachytherapy system described makes use of the latest advances in 
interactive real time 3D graphics and computational power. One of the main advantages of 
this is a shorter calculation time for generating plans. Although surgery is carried out a few 
days after planning, planning time is still limited, and therefore the increased speed and ease 
of use of the program is an advantage. The interactive 3D display enables catheter trajectory 
target and entry co-ordinates to be selected fairly quickly, and enables structures such as 
shunt tubing and blood vessels to be easily avoided. Surface rendering ensures that catheter 
entry points are kept away from previous burr holes and craniotomy flaps. No doubt, with the 
falling size and cost of computers, the system described here could well be implemented on 
future generations of personal computers. 
 
Acknowledgments 
The authors would like to thank the Mick Shields Cancer Trust for generous financial 
support, and Daniel Green and Mark Patrick, formerly of Ardent Computer, Sunnyvale, CA, 
for their programming help in the early stages of the project. 
 
References 
1. FINDLAY, P A, WRIGHT, D C, ROSENOW, U F ET AL , 125-I interstitial brachytherapy 
for primary malignant brain tumours: technical aspects of treatment planning and 
implantation methods, Int. J. Radiat. Oncol. Biol. Phys., 11, 2021-2026 (1985). 
 
2. GUTIN, P H, PHILLIPS, T L, WARA, W M ET AL, Brachytherapy of recurrent malignant 
brain tumours with removable high-activity iodine-125 sources, J. Neurosurg., 60,61-68 
(1984). 
 
3. GUTIN, P H, LEIBEL, S A, WARA, W M ET AL, Recurrent malignant gliomas: survival 
following interstitial brachytherapy with high-activity iodine-125 sources, J. Neurosurg., 
67,864-873 (1987). 
 
4. WRIGHT, A E, Medical Physics Handbook of Radiation Therapy (Medical Physics 
Publications, Madison, WI), pp. 57 (1992). 
 
5. ROSENOW, U F, FINDLAY, P A and WRIGHT, D C. The NCI-atlas of dose distributions 
for regular 125I brain implants, Radiother. Oncol, 10, 127-139 (1987). 
 
6. TEN HAKEN, R K, DIAZ, R F, McSHAN, D L ET AL, From manual to 3-D computerized 
treatment planning for 125-1 stereotactic brain implants, Int. J. Radiat. Oncol. Biol. Phys., 
15,467-480 (1988). 
 
13 
 
7. WEAVER, K, SMITH, V, LEWIS, J D ET AL, A CT-based computerized treatment 
planning system for I-125 stereotactic brain implants, Int. J. Radiat. Oncol. Biol. Phys., 18, 
445-454 (1990). 
 
8. KITCHEN, N D, HUGHES, S W, TAUB, N A ET AL, Survival following interstitial 
brachytherapy for recurrent malignant glioma, J. Neuro-Oncol, 18, 33-39 (1994). 
 
9. GILL, S S, THOMAS, D G T, WARRINGTON, A P and BRADA, M, Relocatable frame 
for stereotactic external beam radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 20, 599-603 
(1991). 
 
10. THOMAS, D G T, GILL, S S, WILSON, C B ET AL, Use of a relocatable stereotactic 
frame to integrate positron emission tomography and computed tomography images: 
application in human malignant brain tumours, Stereotac. Function. Neurosurg., 54-55, 388-
392 (1990). 
 
11. SOFAT, A, HUGHES, S W, BRIGGS, J ET AL, Stereotactic brachytherapy for malignant 
glioma using a relocatable frame, Br. J. Neurosurg., 6, 543-548 (1992). 
 
12. HILL, D L G, HAWKES, D J, CROSSMAN, J E ET AL, Registration of MR and CT 
images for skull base surgery using point-like anatomical features, Br. J. Radiol., 64, 1030-
1035 (1991). 
 
13. THOMAS, D G and NOUBY, R M, Experience in 300 cases of CT-directed stereotactic 
surgery for lesion biopsy and aspiration of haematoma, Br. J. Neurosurg., 3, 321-325 (1989). 
 
14. THOMSON, E S, AFSHAR, F and PLOWMAN, P N, Paediatric brachytherapy. II. Brain 
Implants, Br. J. Radiol., 62, 222-229 (1989). 
 
15. SCHELL, M C, LING, C C, GROMADZKI, Z C and WORKING, K R, Dose 
distributions of model 6702 I-125 seeds in water, Int. J. Radiat. Oncol. Biol. Phys., 13, 795-
799 (1987). 
 
16. BIR/IPSM JOINT WORKING PARTY, Recommendations for Brachytherapy Dosimetry 
(The British Institute of Radiology, London) (1993). 
 
17. KRISHNASWAMY, V, Dose distribution around an 125I seed source in tissue, Radiology, 
126,489-491 (1978). 
 
18. GUTIN, P H and DORMANDY, R H, A coaxial catheter system for afterloading 
radioactive sources for the interstitial irradiation of brain tumours, J. Neurosurg., 56, 734-
735,(1982). 
 
19. BALDOCK, C, HUGHES, S W, SOFAT, A ET AL, Radiation risks to personnel and public 
during the treatment of malignant glioma using interstitial brachytherapy, Br. J. Radiol, 66, 
915-917 (1993). 
